Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$EWLL $0.0006 Volume is rising daily.
Don't miss it.
First target @0.0010 after that resistance we gonna have a lot of fun!
Volume is rising daily.
Gonna be back @ $0.0010 pretty soon!
$EWLL 0.0005 momentum is building up here!
$MMMM lots of gaps to fill. Last Gap is set @ $5.20!
$GXXM I see it @$0.60 pretty soon as longest the momentum is holding up.
$KERN $3.70 looks good here.
MA50 has been broken!
$3.70 looks good here.
MA50 has been broken!
$MMMM $0.40 chart shows a lot of gaps to fill.
In a very good scenario I see $5+ on its way!
$EWLL 0.0004 next huge Lotto-Play!
$MMMM $0.40 next huge winner
$GXXM the next targets are set @ $0.17 , $0.19 and $0.24
$GXXM $0.0636 still rising
$WWR 4.16 breakout imminently
https://www.nyse.com/quote/XASE:WWR
https://schrts.co/uYXkCdFv
Nice run on $GXXM $0.0283
$KERN - Double digits are coming pretty soon !
See you @ double digits pretty soon!
RAFA volume is rising!
RAFA volume gonna boost the price like ABML did
KERN $3.15 Strong buy imo
Gonna run very fast - very tiny float!
https://finviz.com/quote.ashx?t=KERN
RAFA $1.71, ABML $0.1688, NLBS 0.11 & LRDG $ 3.50
TUP $2.62 looks like a bottom here! 100%+ chance imo
http://schrts.co/pGBhjJvh
ABML $0.06x0.065 ready to fly
Green light!
American Battery Metals Corporation Pays Off Convertible Notes to Avoid Potential Equity Dilution
Press Release | 03/04/2020
INCLINE VILLAGE, NV / ACCESSWIRE / March 4, 2020 / American Battery Metals Corporation (OTCQB:ABML) (the "Company"), an American-owned advanced extraction and battery recycling technology company with valuable mineral resources in Nevada, is pleased to announce that it has repaid and satisfied all the convertible notes that had become due and convertible into common stock at a discount to market.
American Battery Metals Corporation Chief Executive Officer, Doug Cole, stated, "As an emerging growth micro-cap publicly traded company, we had to do what was needed to survive and advance our business. With that said, we were grateful to attract funding from institutional convertible notes over the past two years to advance the company to where it is today. However, as additional notes matured and recently became convertible into common stock, we realized the negative effects those conversions were having on the dilution of our stock and the downward pressure on its price. Thus, we have repaid and satisfied these convertible notes in order to avoid any further potential equity dilution. At this time, there are other convertible notes that have yet to mature and currently have no ability to convert into equity. As these other convertible notes get closer to maturity, we are prepared to repay and satisfy them as well to prevent any further equity dilution and to let the stock trade on its own merits. We look forward to keeping our shareholders and the Wall Street community updated as the company continues to meet its goals to become a major U.S. battery metals supplier."
American Battery Metals Corporation
American Battery Metals Corporation (www.batterymetals.com) (OTCQB:ABML) is an American-owned, advanced extraction and battery recycling technology company with valuable mineral resources in Nevada. The company is focused on its lithium-ion battery recycling and resource production projects in Nevada, with the goal of becoming a substantial domestic supplier of battery metals to the rapidly growing electric vehicle and battery storage markets.
For more information, please visit: www.batterymetals.com
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including those with respect to the expected project economics for Western Nevada Basin (Railroad Valley), including estimates of life of mine, average production, cash costs, AISC, initial CAPEX, sustaining CAPEX, pre-tax IRR, pre-tax NPV, net cash flows and recovery rates, the impact of self-mining versus contract mining, the timing to obtain necessary permits, the submission of the project for final investment approval and the timing of initial gold production after investment approval and full financing, metallurgy and processing expectations, the mineral resource estimate, expectations regarding the ability to expand the mineral resource through future drilling, ongoing work to be conducted at the Western Nevada Basin (Railroad Valley), and the potential results of such efforts, the potential commissioning of a Pre-Feasibility study and the effects on timing of the project, are "forward-looking statements." Although the Company's management believes that such forward-looking statements are reasonable, it cannot guarantee that such expectations are, or will be, correct. These forward-looking statements involve a number of risks and uncertainties, which could cause the Company's future results to differ materially from those anticipated. Potential risks and uncertainties include, among others, interpretations or reinterpretations of geologic information, unfavorable exploration results, inability to obtain permits required for future exploration, development or production, general economic conditions and conditions affecting the industries in which the Company operates; the uncertainty of regulatory requirements and approvals; fluctuating mineral and commodity prices, final investment approval and the ability to obtain necessary financing on acceptable terms or at all. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company's filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K for the year ended September 30, 2019. The Company assumes no obligation to update any of the information contained or referenced in this press release.
Contact Information
P:775-473-4744
info@batterymetals.com
SOURCE: American Battery Metals Corporation
PRED NEWS Predictive Technology Group and Atrin Pharmaceuticals Announce Molecular Diagnostic Oncology Development Collaboration
SALT LAKE CITY, Jan. 28, 2020 (GLOBE NEWSWIRE) -- Predictive Technology Group (OTC PINK: PRED) and Atrin Pharmaceuticals LLC are entering into a collaboration agreement to develop molecular diagnostic tools to facilitate improved selection of cancer patients who would most benefit from treatment with DNA Damage and Response (DDR) inhibitors, including Atrin’s and other small molecule ATR inhibitors. Atrin and Predictive will jointly utilize Predictive Laboratories’ state-of-the-art sequencing capabilities and genomics expertise to identify cancer patients with specific molecular markers that predict the level of clinical response to Atrin’s, and other, targeted therapies. This is intended to improve patient outcomes as well as improve Atrin’s ability to successfully progress its product pipeline, and upon commercialization, improve on the treatments for women with cancer.
“We are very pleased to work with Atrin Pharmaceuticals, a recognized leader in the development of anti-cancer therapeutics targeting DDR,” said Bradley Robinson, president and chief executive officer of Predictive Technology Group. “We see an opportunity to develop a precision medicine approach to address unmet medical needs by combining our state-of-the-art sequencing capabilities, genomics expertise and companion diagnostics with Atrin’s targeted therapeutics. This collaboration is consistent with our vision of building a leading women’s health platform, and we look forward to working together on this important initiative.”
Oren Gilad, Ph.D., president and chief executive officer of Atrin Pharmaceuticals, noted: “Following a successful due diligence process, we concluded that Predictive, with its proprietary list of already identified genes and state-of-the-art sequencing capabilities, is the ideal molecular diagnostic partner to help us successfully advance our therapeutic pipeline through clinical development. We believe that this collaboration may become a ‘game changer’ in oncology, as treatment continues to progress towards individualized precision medicine. As we advance multiple Investigational New Drug (IND) applications and progress our lead product candidate ATRN-119 into a first-in-human clinical study this year, Predictive’s portfolio of genomic tests will help us better identify cancer patient populations whose genetic profiles will likely have an optimal clinical response to our proprietary anti-cancer therapeutics.”
The collaboration will help optimize the safety and clinical efficacy of Atrin’s targeted cancer therapeutics and other DDR drug candidates. Atrin will have access to Predictive’s proprietary GenDB databases and women’s health biobank to better understand the clinical spectrum of germline mutations in DDR pathways. The companies will also study common gynecologic disorders, such as endometriosis, associated with the development of cancers in affected patients. The goal of this collaboration is to develop actionable predictive molecular and companion diagnostics and therapeutics for these common disorders and related cancers.
CLSA Capital Markets Limited, a CITIC Securities Company, under its mandate with Predictive Technology Group, will continue to introduce potential strategic partners and provide relevant regulatory guidance to Predictive Technology Group.
About DNA Damage and Response (DDR)
Cells are continuously exposed to endogenous and exogenous stress that can lead to DNA damage. To counter this lethal threat, cells have several mechanisms to detect DNA damage, activate the appropriate repair pathway or, if irreparable, induce cell cycle arrest or apoptosis. These DDR processes are vital for cell survival. Many human diseases, including cancer, and cancer-predisposition syndromes, have been linked to mutations in DDR genes.
About Atrin Pharmaceuticals
Atrin Pharmaceuticals is a private biotech company focused on discovering and developing proprietary therapeutics targeting inhibition of DNA Damage and Response (DDR) proteins for first-line treatment of cancers. Atrin’s technologies and DDR product pipeline represent a new drug development approach for treating solid and other cancers that currently have limited or ineffective therapies by targeting inhibition of specific proteins that are active in cancer cells and relatively inactive in healthy tissue. For more information, visit www.atrinpharma.com.
About Predictive Technology Group, Inc.
Predictive Technology Group aims to revolutionize and personalize precision patient care. The Company and its affiliates harness gene-based analytics to develop genetic and molecular diagnostic tests, as well as companion therapeutics, in order to support a patient from diagnosis through treatment. Predictive’s tests and products enable clinicians to provide their patients with the highest level of care. Predictive’s subsidiaries include Predictive Laboratories, Predictive Biotech and Predictive Therapeutics. For more information, visit www.predtechgroup.com.
About CLSA
CLSA is Asia’s leading capital markets and investment group, providing global investors with insights, liquidity and capital to drive their investment strategies. Award-winning research, an extensive Asia footprint, direct links to China and highly experienced finance professionals differentiate our innovative products and services in asset management, corporate finance, capital and debt markets, securities and wealth management. As the international platform of CITIC Securities (SSE: 600030, SEHK: 6030), China’s largest investment bank, CLSA is uniquely positioned to facilitate cross-border capital flows and connect China with the world and the world to China. Founded in 1986 and headquartered in Hong Kong, CLSA’s global network spans 20 locations across Asia, Australia, Europe and the United States. For more information, visit www.clsa.com.
Forward-Looking Statements:
To the extent any statements made in this release contain information that is not historical, these statements are essentially forward-looking and are subject to risks and uncertainties, including the difficulty of predicting FDA approvals, acceptance and demand for human cell and tissue products and other pharmaceutical products, the impact of competitive products and pricing, new product development and launch, reliance on key strategic alliances, availability of raw materials, availability of additional intellectual property rights, availability of future financing sources, the regulatory environment, and other risks the Company may identify from time to time in the future.
Contacts:
For more information, visit www.predtechgroup.com or contact:
Media Contact
Patrick Bursey
LifeSci Communications
pbursey@lifescicomms.com
646-876-4932
Investor Contact
Jeremy Feffer
LifeSci Advisors
jeremy@lifesciadvisors.com
212-915-2568
Source: Predictive Technology Group Inc © 2020 GlobeNewswire, Inc.
KinerjaPay Corp (KPAY: OTCQB) Expects to Receive Bank Guarantee of $30 MillionPress Release | 01/27/2020
KinerjaPay Corp (KPAY: OTCQB) Expects to Receive Bank Guarantee of $30 MillionThis is a vital development prior to Activating its $25 Million Credit Facility
PR Newswire
JAKARTA, Indonesia, Jan. 27, 2020
JAKARTA, Indonesia, Jan. 27, 2020/PRNewswire/ -- The Company's representative confirms today that its local bank in Jakarta, Indonesia, China Construction Bank, Jakarta will receive a SWIFT transmission of a $30 million, Bank of China, MT-799 within this week currently being scheduled on January 29th, 2020. The MT-799 is a pre-advice transmission alerting KinerjaPay Corp's bank to accept a final transmission of the actual Bank of China MT-760 bank guarantee. The terms of our non-recourse, $25 million credit facility allows the Company to draw down a net $22.5 millionevenly over three months. The first drawdown should be within days of the receipt of the MT-760. We expect to receive the final MT-760 within a short period after the banks reopen after the Chinese New Year holiday break. The MT-799 will be sent on behalf of Infinity Venture Capital Pte. Ltd., a Singaporean based corporation owned by Indonesian investors. On January 22, 2020, Infinity executed a $200 million subscription agreement for a series of convertible preferred which converts into equity at $1.80/share with a 7% annual dividend. This convertible preferred has no anti-dilution rights. Upon receipt of the first $22.5 million, the Company will deliver the same value of the convertible preferred series mentioned above. It is Infinity's intention to deliver the remaining $177.5 million in the same manner, as fast as the Company's bank will increase the credit facility to lend on non-recourse basis versus these guarantees.
Mr. Edwin W. Ng, CEO of KinerjaPay Corp. (OTCQB: KPAY) said: "We are excited to finally conclude our negotiation with our Investor to receive the Bank Guarantee that we need to begin the first equity round under the credit line process. We have gone through an extensive education to finally reach our goal of using these bank guarantees to fund our KFUND lending operations, as well as other uses that we have previously disclosed. We are still awaiting Gabriel Capital Ltd.'s right sized bank guarantee. They have been having trouble breaking up their commitment into guarantees smaller than $100 million at a time. We are also in advanced discussions with several other groups to send MT-760 guarantees acceptable to our bank. We are gratified that Infinity believes enough in KPAY's ecommerce and lending platform such that they committed equity at a substantial premium to our currently traded stock price. They agree we have a bright future! With the proceeds of the investment, we intend to pay off our convertible debt, which has been depressing the stock price, as well as advance our previously announced stock buy back program. We believe the Company's year-long attempt to raise substantial equity is nearing its end."
About KinerjaPay
KinerjaPay enables consumers to "Pay, Play and Buy" through its secure web portal and mobile applications. Based in Indonesia, the Company provides an easy and convenient payment solution while shopping online at its marketplace platform. With its current omni-channel platform, users can perform various payment services such as credit card bill payment, utility, phone bill, healthcare insurance and direct transfer to anyone at their convenience. KinerjaPay is also planning to launch other eCommerce verticals such as travel market, delivery services, and online gaming in the near future. The Company's services are available through its mobile applications and on its website at www.kinerjapay.com.
Notice Regarding Forward-Looking Statements
This press release may contain forward-looking statements, about KPAY's expectations, beliefs or intentions regarding, among other things, its product development efforts, business, financial condition, results of operations, strategies or prospects. In addition, from time to time, KPAY or its representatives have made or may make forward-looking statements, orally or in writing.
Forward-looking statements can be identified by the use of forward-looking words such as "believe," "expect," "intend," "plan," "may," "should" or "anticipate" or their negatives or other variations of these words or other comparable words or by the fact that these statements do not relate strictly to historical or current matters. These forward-looking statements may be included in, but are not limited to, various filings made by KPAY with the U.S. Securities and Exchange Commission, press releases or oral statements made by or with the approval of one of KPAY's authorized executive officers. Forward-looking statements relate to anticipated or expected events, activities, trends or results as of the date they are made. Because forward looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause KPAY's actual results to differ materially from any future results expressed or implied by the forward-looking statements. Many factors could cause KPAY's actual activities or results to differ materially from the activities and results anticipated in such forward-looking statements, including, but not limited to, the factors summarized in KPAY 's filings with the SEC. In addition, KPAY operates in an industry sector where securities values are highly volatile and may be influenced by economic and other factors beyond its control. KPAY does not undertake any obligation to publicly update these forward-looking statements, whether as a result of new information, future events or otherwise. Please see the risk factors associated with an investment in our securities which are included in our Annual Report on Form 10-K as filed with the SEC on April 20, 2018 and most recently in our Registration Statement on Form S-1/A filed with the SEC on December 21, 2018, pursuant to which we are offering 300,000 Shares of 11% Series C Cumulative Redeemable Perpetual Preferred Stock at $25.00 Per Share.
For more information, please visit our website http://www.kinerjapay.co. There you will find access to all of our past press releases and SEC filings regarding the activities discussed in this release.
Media Contact:
KinerjaPay Corp.
Email: info@kinerjapay.co
+62-21-2918-1336
View original content:http://www.prnewswire.com/news-releases/kinerjapay-corp-kpay-otcqb-expects-to-receive-bank-guarantee-of-30-million-300993424.html
SOURCE KinerjaPay Corp.
Gap-Fill is coming closer
PRED next target @$1.60 (gap-fill)
Gonna face resistance @ $2.50 imo
PRED Insiderbuy 10k @$0.84 by CEO
PREDICTIVE TECHNOLOGY GROUP, INC. (Form: 4, Received: 11/21/2019 08:19:12)
https://www.otcmarkets.com/filing/html?id=13754939&guid=DR_vUnVR-IjoD3h
Predictive Technologies Group Engages LifeSci Partners as Communications PartnerPress Release | 10/31/2019
SALT LAKE CITY, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTCQX: PRED) (“Predictive” or “The Company”), a leader in the development of genetic and molecular diagnostics and companion therapeutics, announced that it has engaged with LifeSci Partners (“LifeSci”) to increase awareness of the company’s brand and clinical programs.
“We are excited to work with LifeSci to inform the public and the investment community about our innovative data analytics that help physicians identify and combat diseases using our unique treatments and therapeutics,” said Bradley C. Robinson, president and chief executive officer of Predictive. “LifeSci’s expertise in investor relations and public relations, as well as their decades of experience in capital markets, media relations and scientific research have made them the perfect communications partner for our company as we work to grow our business and reach new audiences.”
LifeSci is a leading provider of strategic consulting services in the areas of investor relations, public relations, corporate communications, executive search and capital markets advisory. LifeSci Advisors, LLC and LifeSci Public Relations will provide Predictive with integrated communications services through strategic messaging, investor and media outreach, social and digital media efforts.
Predictive Technologies Group PRED Upgrades to OTCQX® Best MarketPress Release | 10/24/2019
SALT LAKE CITY, Oct. 24, 2019 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTCQX: PRED), a leader in the development of genetic and molecular diagnostics and companion therapeutics, today announced that the company has been upgraded to the OTCQX® Best Market from the Pink® market. Effective today, the company’s shares will trade under the ticker “PRED.” U.S. investors can find current financial disclosures and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
“We are pleased to upgrade to the OTCQX® Best Market and believe this is a testament to the Predictive team who work to continuously improve our financial standards and corporate governance practices,” said Bradley C. Robinson, President and Chief Executive Officer of Predictive Technologies Group. “We welcome the broader investor reach and heightened visibility among the investment community that the OTCQX® Best Market confers on its traded companies.”
“We are pleased to be accepted to trade on the OTCQX Best Market. Our previously announced listing application for the NASDAQ Market exchange is currently in the review process,” Mr. Robinson concluded.
Burns Figa & Will PC acted as the company’s OTCQX sponsor.
KPAY News
KinerjaPay Corp. (KPAY) Successfully Negotiated an Initial $25 Million Non-recourse Credit Facility With Its Local BankPress Release | 10/23/2019
KinerjaPay Corp. (KPAY) Successfully Negotiated an Initial $25 Million Non-recourse Credit Facility With Its Local Bank- Gabriel Capital Ltd. will provide a Major Bracket Bank guarantee underlying the KPAY Credit Facility- Gabriel also subscribed to $200 million of KPAY Preferred Stock, convertible at $1.80 per share
PR Newswire
JAKARTA, Indonesia, Oct. 23, 2019
JAKARTA, Indonesia, Oct. 23, 2019/PRNewswire/ -- KinerjaPay Corp., (OTCQB: KPAY), has successfully concluded negotiations with its local bank, China Construction Bank Indonesia (CCBI), which will provide the Company with a $25 million, non-recourse credit facility. This credit facility will be accessed by the Company utilizing the Gabriel Capital Ltd. ("Gabriel") HSBC bank guarantee, the draft of which has already been approved by the Bank's Credit Committee. Gabriel is a privately-owned, Indonesian family controlled entity, based in Singapore. The final HSBC bank guarantee for $25 million is expected to be received in KinerjaPay's account with CCBI within the week. Upon delivery of the collateral, KinerjaPay will draw down the guaranteed net proceeds of $22.5 million in three monthly tranches of $7.5 millioncommencing within 48 hours of receipt of the final bank guarantee. Upon each draw, KPAY will issue Gabriel a proportionate number of shares of Series F and G Preferred Stock under Gabriel's executed Reg S Subscription Agreements, based upon the net subscription proceeds. Gabriel intends to continue delivering such guarantees until the full $200 million is received under these Subscription Agreements.
CCBI will fund on a non-recourse basis supported by the collateral underlying the Gabriel guarantee. In effect, Gabriel is making an equity investment in KinerjaPay Corp.'s Preferred Stock, which is being issued in consideration for Gabriel's guarantee. The Series F Convertible Preferred Stock is convertible into shares of Common Stock at an average of $1.80 per share. The Series G Preferred Stock provides for KPAY's sole right to affect the conversion into Common Stock at $1.80 per share provided that the KPAY shares are trading at $3.50 or higher for a period of 20 days commencing six months after the dates of issuance of the Series G Preferred Stock. Gabriel, however, does not have the right to elect to convert the Series G Preferred Stock at its option.
The Company's Chairman and CEO, Mr. Edwin Ng commented, "We are extremely pleased to have completed the negotiation process with the local Bank for the non-recourse credit facility. We are also very fortunate to be supported by Gabriel Capital Ltd.'s equity investment in KPAY's Preferred Stock, shares of which shall issued upon receipt of the final HSBC bank guarantee. We have put in place an equity financing structure to enable KPAY to be at the forefront of Indonesian growth in key business and financial sectors." Mr. Agoeng Noegroho, the Chief Investment Officer of the Singapore-based Gabriel Capital Ltd. stated "We view our $200 million investment commitment, of which this first tranche of $25 million will close upon the delivery of our collateral, as evidence of our belief in Indonesia's growth and KPAY's ability to invest in exciting US technologies suitable for integration into the rapidly growing South East Asia economy."
Gap @$2.34 has been closed.
Yes Mike it looks very bullish to me.
We have turned positive on the ChiOsc yesterday also.
PRED $2.80 close - $3.30 Gap gonna be filled next week imo
Already 75% up from $1.60 call
PRED $2.24 close - Gap gonna be filled very fast imo
Already 40% up from $1.60 call
Great find, thank you Mike!
PRED $1.60 Gap-Fill-Play @3.30
PRED has tanked by a massive short-attack-report
https://seekingalpha.com/article/4274333-predictive-technology-95-percent-downside-executive-red-flags-believed-self-dealing-dubious
PRED looks like gap fill @$5.21 gonna happen today.
Gaps to fill @$8.66 & $9.85